Bomyntra Injection
Product Images NDC 65219-672

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Bomyntra (NDC 65219-672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tra1b 0001 01)

An instructional diagram showing a BOMYNTRA (Denosumab) 70 mg/mL injection syringe before and after use. Key parts labeled include the needle cap, clear needle guard, liquid-filled syringe barrel, plunger, needle covered after use, and needle guard spring retracted post-injection.*

FDA Label Image

Figure A (Tra1b 0001 02)

An instructional illustration depicting hands preparing a syringe for injection. One hand holds a syringe labeled with a product name and measurement markings, while the other hand removes a protective cap from the needle, indicated by an arrow showing the direction of removal.*

FDA Label Image

Figure B (Tra1b 0001 03)

An instructional diagram showing recommended subcutaneous injection sites for BOMYNTRA (Denosumab) 70 mg/mL injection. Highlighted injection areas are on the outer upper arms and the front of the thighs and lower abdomen of a human figure shown from front and back views.*

FDA Label Image

Figure C (Tra1b 0001 04)

An instructional illustration showing a hand holding a BOMYNTRA (denosumab) injection device being used for subcutaneous administration. A close-up inset highlights the plunger mechanism with an arrow indicating the direction of pressing to inject the medication.*

FDA Label Image

Figure D (Tra1b 0001 05)

An instructional illustration showing a hand holding a BOMYNTRA (denosumab) 70 mg/mL subcutaneous injection syringe, positioned for administration into the skin with an arrow indicating upward motion for injection removal or activation.*

FDA Label Image

Figure 1 (Tra1b 0001 06)

A line graph depicting corrected calcium levels over time in a study with 23 subjects receiving 120 mg Denosumab. The x-axis represents study days, from baseline (BL) to day 57, and the y-axes show corrected calcium in mmol/L (left) and mg/dL (right). Data points include error bars indicating variability.*

FDA Label Image

Logo (Tra1b 0001 07)

BOMYNTRA 70 mg/mL injection label for subcutaneous use. The label displays the brand name BOMYNTRA prominently with the generic name Denosumab below. It includes the logo and name of the labeler, Fresenius Kabi USA, LLC, and shows the concentration strength 70 mg/mL. The label design features blue and white colors with branding elements.*

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Pfs Carton Label (Tra1b 0001 08)

BOMYNTRA denosumab-bnht injection carton label displaying 120 mg/1.7 mL (70 mg/mL) strength for subcutaneous use. The single-dose prefilled syringe packaging includes one syringe and prescribing information. Labeler is Fresenius Kabi USA, LLC. The label warns to discard unused portion and to have administration by a healthcare provider.*

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Syringe Label (Tra1b 0001 09)

Label for Bomyntra 120 mg/1.7 mL (70 mg/mL) injection, containing denosumab for subcutaneous use. The label shows the product name, dosage strength, route of administration, and is marked Rx only. Labeler is Fresenius Kabi USA, LLC, with U.S. license number 2146. The label includes an NDC number and barcode.*

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Carton Label (Tra1b 0001 10)

Packaging label for Bomyntra (denosumab-bnht) injection, 120 mg/1.7 mL (70 mg/mL), a sterile solution for subcutaneous use only. The label indicates it is a single-dose vial, with instructions to discard any unused portion. The labeler is Fresenius Kabi USA, LLC, and the packaging includes a barcode, lot, expiration, and serial number fields, along with a QR code for additional information.*

FDA Label Image

Principal Display Panel – 120 mg/1.7 mL Syringe Label (Tra1b 0001 11)

Label for BOMYNTRA injection by Fresenius Kabi USA, LLC, containing denosumab 120 mg/1.7 mL (70 mg/mL) in a single-dose vial for subcutaneous use only. Includes NDC 65219-670-01, Rx only designation, and instructions to discard unused portion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.